Quantum Genomics are the creators of Firibastat, a first in class brain aminopeptidase inhibitor (BAPAI) that could potentially treat treatment-resistant hypertension by acting in the brain to interfere with the renin-angiotensin system. For details visit: http://www.quantum-genomics.com/
Advances in medicine causes new, groundbreaking drug by Quantum Genomics (QNNTF) to help with the chronic hypertension
Quantum Genomics are the creators of Firibastat, a first in class brain aminopeptidase inhibitor (BAPAI) that could potentially treat treatment-resistant hypertension by acting in the brain to interfere with the renin-angiotensin system. For details visit: http://www.quantum-genomics.com/
ConversionConversion EmoticonEmoticon
Note: Only a member of this blog may post a comment.